Y. John Wang
Y. John Wang publishes mostly in Molecular Biology, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, on topics such as Protein purification and stability, Viral Infectious Diseases and Gene Expression in Insects and Drug Solubulity and Delivery Systems.
- World rank
- #2,768,304 of 7,710,434 ranked researchers
- Rank in United States
- #804,688 of 1,627,098
- Works
- 16
- Citations
- 802
- Citations per work
- 50.1
What does Y. John Wang research?
Y. John Wang's work is mostly in Biochemistry, Genetics and Molecular Biology (47%), Pharmacology, Toxicology and Pharmaceutics (13%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1062.1%
- Everything else424.5%
- Physical Sciences16.7%
- Chemistry16.7%
- Health Sciences16.7%
- Medicine16.7%
- 1Molecular Biology42% of their works
- 2Pharmaceutical Science13% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Spectroscopy7% of their works
- 5Clinical Biochemistry4% of their works
- 6Animal Science and Zoology2% of their works
Research topics
- Protein purification and stability
- Viral Infectious Diseases and Gene Expression in Insects
- Drug Solubulity and Delivery Systems
- Monoclonal and Polyclonal Antibodies Research
- Advanced Glycation End Products research
- Redox biology and oxidative stress
- Advanced Drug Delivery Systems
- Mass Spectrometry Techniques and Applications
Which keywords describe Y. John Wang's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Protein Aggregation, Glycosylation, Oxidative Stress, Antibody Engineering and Cyclodextrins.
- Redox Regulation
- Nanoparticles
- Ionization
- Chitosan
- Solid Dispersions
- Mammalian Cells
- Cyclodextrins
- Oxidative Stress
- Protein Aggregation
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Glycosylation
- Antibody Engineering
- Fc Receptors
- Recombinant Protein
- Advanced Glycation End Products
- HMGB1
- Mass Spectrometry
- Reactive Oxygen Species
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Monoclonal Antibodies112 topics
- Therapeutic Antibodies112 topics
- Biopharmaceuticals81 topic
- Protein Aggregation81 topic
- Glycosylation62 topics
- Oxidative Stress42 topics
- Antibody Engineering31 topic
- Cyclodextrins31 topic
- Fc Receptors31 topic
- Mammalian Cells31 topic
- Recombinant Protein31 topic
- Solid Dispersions31 topic
- Advanced Glycation End Products21 topic
- Chitosan21 topic
- HMGB121 topic
- Ionization21 topic
- Mass Spectrometry21 topic
- Nanoparticles21 topic
- Reactive Oxygen Species21 topic
- Redox Regulation21 topic
Where does Y. John Wang work?
Y. John Wang's main affiliation in the publication record is Pharmaceutical Product Development (United States), United States.
How many publications and citations does Y. John Wang have?
OpenAlex counts 16 works and 802 citations for Y. John Wang, an h-index of 14, ranking #2,768,304 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Y. John Wang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.